Log in
Enquire now
Nkarta Therapeutics

Nkarta Therapeutics

Nkarta Therapeutics is a biotechnology company using natural killer (NK) immune cells for cellular therapies.

OverviewStructured DataIssuesContributors

Contents

nkartatx.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Internal medicine
Internal medicine
Cell therapy
Cell therapy
Stem cell
Stem cell
Healthcare
Healthcare
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Cancer
Cancer
...
Location
San Francisco
San Francisco
South San Francisco, California
South San Francisco, California
0
B2X
B2B
B2B
CEO
‌
Paul Hastings
0
Founder
‌
Paul Hastings
Pitchbook URL
pitchbook.com/profiles...222039-01
Legal Name
Nkarta Inc.
Date Incorporated
2015
Number of Employees (Ranges)
51 – 2000
Email Address
Phone Number
Full Address
6000 Shoreline Court Suite 102 South San Francisco CA 940800
Investors
SR One
SR One
Life Science Quest
Life Science Quest
Deerfield Management
Deerfield Management
Amgen Ventures
Amgen Ventures
RA Capital Management
RA Capital Management
Novo Holdings A/S
Novo Holdings A/S
NEA (New Enterprise Associates)
NEA (New Enterprise Associates)
Logos Capital
Logos Capital
Founded Date
2015
Total Funding Amount (USD)
114,000,000
Latest Funding Round Date
September 2019
Stock Symbol
NKTX
Exchange
Nasdaq
Nasdaq
Glassdoor ID
2985168
Board of Directors
‌
Fouad Azzam
0
‌
Tiba Aynechi
0
‌
Zach Scheiner
0
‌
Leone Patterson
0
‌
Paul Hastings
0
‌
Simeon George
0
‌
Laura Shawver
0
‌
Mike Dybbs
0
...
CFO
‌
Nadir Mahmood
0
Key People
‌
Jeff Smith
‌
Matthew Plunkett
‌
Nadir Mahmood
0
‌
Kanya Rajangam
‌
Greg Mann
‌
Yvonne Lii
‌
Don Hong Wang
‌
James Trager
0
...
Latest Funding Type
Series B
Series B
Technologies Used
CRISPR
CRISPR
Country
United States
United States
0

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
114,000,000
Public/Private
Public
Ticker Symbol
NKTX0
Wikidata ID
Q107518637

Nkarta Therapeutics is a biotechnology company using natural killer (NK) immune cells for cellular therapies that is headquartered in South San Francisco, California and was founded in 2015 by Dario Campana.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

NKARTA THERAPEUTICS ANNOUNCES EXCLUSIVE LICENSE TO NATURAL KILLER CELL TECHNOLOGY FROM NATIONAL UNIVERSITY OF SINGAPORE AND ST. JUDE CHILDREN’S RESEARCH HOSPITAL

Nkarta

https://www.nkartatx.com/news/061118/

Web

Nkarta Therapeutics Expands Management Team and Establishes New Corporate Headquarters

Nkarta

https://www.globenewswire.com/news-release/2018/07/09/1534583/0/en/Nkarta-Therapeutics-Expands-Management-Team-and-Establishes-New-Corporate-Headquarters.html

Web

Nkarta Therapeutics Reports Potent Natural Killer Cell Anti-Cancer Activity in Preclinical Tumor Model

Nkarta

https://www.globenewswire.com/news-release/2018/11/09/1648925/0/en/Nkarta-Therapeutics-Reports-Potent-Natural-Killer-Cell-Anti-Cancer-Activity-in-Preclinical-Tumor-Model.html

Web

References

Find more companies like Nkarta Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.